Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF for Prevention of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation
NCT01232504Phase 4Completed
- Sponsor
- Xiamen Tebao Biological Engineering Co., Ltd.
- Start
- Sep 2009
- Primary completion
- Mar 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of sargramostim in invasive fungal disease (IFD), sponsored by Xiamen Tebao Biological Engineering Co., Ltd.. Started Sep 2009; status: completed.
02
Drugs
sargramostim
03
Conditions
invasive fungal disease (IFD)
Beyond the preview
Go deeper on NCT01232504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01232504.